Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $310,876 - $379,928
1,526 New
1,526 $359,000
Q2 2020

Aug 05, 2020

SELL
$113.31 - $182.44 $6.82 Million - $11 Million
-60,200 Closed
0 $0
Q3 2019

Nov 06, 2019

SELL
$159.77 - $178.1 $10.1 Million - $11.3 Million
-63,465 Reduced 51.32%
60,200 $10.1 Million
Q2 2019

Aug 07, 2019

BUY
$144.16 - $172.9 $13 Million - $15.6 Million
90,265 Added 270.25%
123,665 $10.4 Million
Q4 2018

Feb 12, 2019

SELL
$120.82 - $174.09 $10.3 Million - $14.8 Million
-85,000 Reduced 71.79%
33,400 $4.22 Million
Q3 2017

Nov 13, 2017

SELL
$149.47 - $160.56 $17.2 Million - $18.5 Million
-115,000 Reduced 49.27%
118,400 $17.9 Million
Q2 2017

Aug 11, 2017

BUY
N/A
233,400
233,400 $36 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Banco Santander, S.A. Portfolio

Follow Banco Santander, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.